Regulation of autophagy protects against liver injury in liver surgery-induced ischaemia/reperfusion

J Cell Mol Med. 2021 Nov;25(21):9905-9917. doi: 10.1111/jcmm.16943. Epub 2021 Oct 8.

Abstract

Transient ischaemia and reperfusion in liver tissue induce hepatic ischaemia/reperfusion (I/R) tissue injury and a profound inflammatory response in vivo. Hepatic I/R can be classified into warm I/R and cold I/R and is characterized by three main types of cell death, apoptosis, necrosis and autophagy, in rodents or patients following I/R. Warm I/R is observed in patients or animal models undergoing liver resection, haemorrhagic shock, trauma, cardiac arrest or hepatic sinusoidal obstruction syndrome when vascular occlusion inhibits normal blood perfusion in liver tissue. Cold I/R is a condition that affects only patients who have undergone liver transplantation (LT) and is caused by donated liver graft preservation in a hypothermic environment prior to entering a warm reperfusion phase. Under stress conditions, autophagy plays a critical role in promoting cell survival and maintaining liver homeostasis by generating new adenosine triphosphate (ATP) and organelle components after the degradation of macromolecules and organelles in liver tissue. This role of autophagy may contribute to the protection of hepatic I/R-induced liver injury; however, a considerable amount of evidence has shown that autophagy inhibition also protects against hepatic I/R injury by inhibiting autophagic cell death under specific circumstances. In this review, we comprehensively discuss current strategies and underlying mechanisms of autophagy regulation that alleviates I/R injury after liver resection and LT. Directed autophagy regulation can maintain liver homeostasis and improve liver function in individuals undergoing warm or cold I/R. In this way, autophagy regulation can contribute to improving the prognosis of patients undergoing liver resection or LT.

Keywords: autophagy; cell death; ischaemia/reperfusion; liver resection; liver transplantation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Autophagy* / drug effects
  • Biomarkers
  • Disease Management
  • Disease Susceptibility
  • Gene Expression Regulation / drug effects
  • Hepatectomy / adverse effects
  • Hepatectomy / methods
  • Humans
  • Ischemic Preconditioning / methods
  • Liver Diseases / etiology*
  • Liver Diseases / metabolism*
  • Liver Diseases / pathology
  • Liver Diseases / prevention & control
  • Liver Transplantation / adverse effects
  • Liver Transplantation / methods
  • Mitochondria, Liver / drug effects
  • Mitochondria, Liver / metabolism
  • Mitophagy
  • Protective Agents / pharmacology*
  • Protective Agents / therapeutic use
  • Reperfusion Injury / etiology*
  • Reperfusion Injury / metabolism*
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control
  • Signal Transduction / drug effects

Substances

  • Biomarkers
  • Protective Agents